Two days after President Barack Obama canceled plans to meet Russian President Vladimir Putin in Moscow next month, their foreign and defense ministers met in Washington today in an effort to bridge differences.
Roche Holding AG delayed development of the experimental diabetes drug taspoglutide by at least 12 to 18 months after more people than expected suffered from side effects such as skin reactions and digestive symptoms.
Actelion Ltd., the Swiss drugmaker that gets almost 90 percent of sales from a treatment for a rare lung disease, raised its full-year profit forecast as second- quarter sales beat estimates and it cut spending.
Ukrainian President Viktor Yanukovych signed a peace agreement with opposition leaders that calls for early elections and reduced presidential powers in a bid to halt a deadly, three-month political crisis.
Roche Holding AG forecast that revenue will rise by a low to mid-single-digit percentage this year and profit will increase faster as sales climb for its biggest cancer drugs and a slate of new therapies.